Clinical value of chip-based digital-PCR platform for the detection of circulating DNA in metastatic colorectal cancer-Reference-Cited by-同舟云学术

Clinical value of chip-based digital-PCR platform for the detection of circulating DNA in metastatic colorectal cancer

Published:2015-10 Issue:10 Volume:47 Page:884-890
ISSN:1590-8658
Container-title:Digestive and Liver Disease
language:en
Short-container-title:Digestive and Liver Disease

Author:

Sefrioui David,Sarafan-Vasseur Nasrin^ORCID,Beaussire Ludivine^ORCID,Baretti Marina^ORCID,Gangloff Alice,Blanchard France,Clatot Florian,Sabourin Jean-Christophe,Sesboüé Richard,Frebourg Thierry,Michel Pierre,Di Fiore Frédéric

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference29 articles.

1. Implementing personalized cancer genomics in clinical trials;Simon;Nature Reviews Drug Discovery,2013

2. Implementing prognostic and predictive biomarkers in CRC clinical trials;Van Schaeybroeck;Nature Reviews Clinical Oncology,2011

3. Colorectal cancer in 2013: towards improved drugs, combinations and patient selection;Schmoll;Nature Reviews Clinical Oncology,2014

4. Prognostic value of circulating mutant DNA in unresectable metastatic colorectal cancer;Lefebure;Annals of Surgery,2010

5. Detection of circulating tumor DNA in early- and late-stage human malignancies;Bettegowda;Science Translational Medicine,2014

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Prognostic Utility of KRAS Mutations in Tissue and Circulating Tumour DNA in Colorectal Cancer Patients;Gastroenterology Insights;2024-01-27

2. Microfluidic-based technologies in cancer liquid biopsy: Unveiling the role of horizontal gene transfer (HGT) materials;Environmental Research;2023-12

3. Correlation Analyses between Histological Staging and Molecular Alterations in Tumor-Derived and Cell-Free DNA of Early-Stage Primary Cutaneous Melanoma;Cancers;2023-10-25

4. A Chamber-Based Digital PCR Based on a Microfluidic Chip for the Absolute Quantification and Analysis of KRAS Mutation;Biosensors;2023-08-01

5. Role of circulating-tumor DNA in the early-stage non-small cell lung carcinoma as a predictive biomarker;Pathology - Research and Practice;2023-05